For help on how to get the results you want, see our search tips.
7 results
Categories
Human Remove Human filter
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Withdrawn applications Remove Withdrawn applications filter
Direct healthcare professional communication Remove Direct healthcare professional communication filter
Summaries of opinion Remove Summaries of opinion filter
Medicine type
Accelerated assessment Remove Accelerated assessment filter
Exceptional circumstances Remove Exceptional circumstances filter
Additional monitoring Remove Additional monitoring filter
Biosimilar Remove Biosimilar filter
Orphan medicine Remove Orphan medicine filter
Opinion status
Positive Remove Positive filter
Application type
Initial authorisation Remove Initial authorisation filter
-
List item
Summary of opinion: Nexviadyme
Avalglucosidase alfa, opinion date: 23/07/2021, Positive, Last updated: 02/08/2021 -
List item
Summary of opinion: Oxbryta
Voxelotor, opinion date: 16/12/2021, Positive, Last updated: 17/12/2021 -
List item
Summary of opinion: Rybrevant
amivantamab, opinion date: 14/10/2021, Positive, Last updated: 15/10/2021 -
List item
Summary of opinion: Lumykras
sotorasib, opinion date: 11/11/2021, Positive, Last updated: 12/11/2021 -
List item
Summary of opinion: Lonapegsomatropin Ascendis Pharma
lonapegsomatropin, opinion date: 11/11/2021, Positive, Last updated: 12/11/2021 -
List item
Summary of opinion: Tecovirimat SIGA
tecovirimat, opinion date: 11/11/2021, Positive, Last updated: 12/11/2021 -
List item
Summary of opinion: Wegovy
semaglutide, opinion date: 11/11/2021, Positive, Last updated: 12/11/2021